US Stock MarketDetailed Quotes

TLX Telix Pharmaceuticals

Watchlist

15.600
-0.170-1.08%

Close Dec 12 16:00 ET

5.49BMarket Cap175.28P/E (TTM)

Telix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 30, 2023

(FY)Dec 30, 2022

(FY)Dec 30, 2021

(FY)Dec 30, 2020

(FY)Dec 30, 2019

Total revenue

218.40%496.66M

3,084.65%155.98M

4.66%4.9M

34.29%4.68M

3.49M

Operating revenue

218.40%496.66M

3,084.65%155.98M

4.66%4.9M

34.29%4.68M

--3.49M

Cost of revenue

205.67%188.16M

2,315.86%61.56M

25.89%2.55M

-20.41%2.02M

2.54M

Gross profit

226.71%308.5M

3,918.21%94.43M

-11.52%2.35M

181.95%2.66M

942K

Operating expense

42.13%269.27M

87.29%189.44M

92.88%101.15M

27.29%52.44M

41.2M

Selling and administrative expenses

43.15%133.85M

129.12%93.5M

112.46%40.81M

65.77%19.21M

--11.59M

-Selling and marketing expense

238.96%54.87M

174.78%16.19M

390.10%5.89M

285.26%1.2M

--312K

-General and administrative expense

2.16%78.99M

121.42%77.32M

93.93%34.92M

59.70%18.01M

--11.28M

Research and development costs

122.69%128.84M

69.49%57.86M

47.87%34.14M

9.09%23.09M

--21.16M

Depreciation amortization depletion

25.36%6.74M

3.96%5.38M

5.98%5.17M

15.25%4.88M

--4.24M

-Depreciation and amortization

25.36%6.74M

3.96%5.38M

5.98%5.17M

15.25%4.88M

--4.24M

Other operating expenses

-100.53%-173K

55.50%32.7M

299.30%21.03M

25.02%5.27M

--4.21M

Operating profit

141.29%39.24M

3.83%-95.02M

-98.45%-98.8M

-23.67%-49.79M

-40.26M

Net non-operating interest income expense

-90.57%-12.75M

-28.25%-6.69M

-370.94%-5.22M

52.03%-1.11M

-2.31M

Non-operating interest income

101,800.00%1.02M

--1K

----

-31.63%67K

--98K

Non-operating interest expense

104.74%13.14M

22.96%6.42M

344.09%5.22M

-51.20%1.18M

--2.41M

Total other finance cost

129.60%636K

--277K

----

Other net income (expense)

-1,076.64%-30.14M

-86.90%3.09M

695.98%23.55M

-74.14%2.96M

11.44M

Special income (charges)

---804K

----

-Less:Impairment of capital assets

--804K

----

Other non- operating income (expenses)

-1,050.58%-29.34M

-86.90%3.09M

695.98%23.55M

-74.14%2.96M

--11.44M

Income before tax

103.13%3.09M

-22.57%-98.62M

-67.86%-80.47M

-54.02%-47.94M

-31.12M

Income tax

-138.92%-2.12M

12,026.67%5.46M

101.48%45K

6.36%-3.05M

-3.26M

Net income

105.01%5.21M

-29.27%-104.08M

-79.36%-80.51M

-61.08%-44.89M

-27.87M

Net income continuous Operations

105.01%5.21M

-29.27%-104.08M

-79.36%-80.51M

-61.08%-44.89M

---27.87M

Minority interest income

Net income attributable to the parent company

105.01%5.21M

-29.27%-104.08M

-79.36%-80.51M

-61.08%-44.89M

-27.87M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

105.01%5.21M

-29.27%-104.08M

-79.36%-80.51M

-61.08%-44.89M

-27.87M

Basic earnings per share

104.81%0.0161

-17.54%-0.335

-63.32%-0.285

-46.15%-0.1745

-0.1194

Diluted earnings per share

104.81%0.0161

-17.54%-0.335

-63.32%-0.285

-46.15%-0.1745

-0.1194

Dividend per share

Currency Unit

AUD

Accounting Standards

US-GAAP

	(FY)Dec 30, 2023	(FY)Dec 30, 2022	(FY)Dec 30, 2021	(FY)Dec 30, 2020	(FY)Dec 30, 2019
Total revenue	218.40%496.66M	3,084.65%155.98M	4.66%4.9M	34.29%4.68M	3.49M
Operating revenue	218.40%496.66M	3,084.65%155.98M	4.66%4.9M	34.29%4.68M	--3.49M
Cost of revenue	205.67%188.16M	2,315.86%61.56M	25.89%2.55M	-20.41%2.02M	2.54M
Gross profit	226.71%308.5M	3,918.21%94.43M	-11.52%2.35M	181.95%2.66M	942K
Operating expense	42.13%269.27M	87.29%189.44M	92.88%101.15M	27.29%52.44M	41.2M
Selling and administrative expenses	43.15%133.85M	129.12%93.5M	112.46%40.81M	65.77%19.21M	--11.59M
-Selling and marketing expense	238.96%54.87M	174.78%16.19M	390.10%5.89M	285.26%1.2M	--312K
-General and administrative expense	2.16%78.99M	121.42%77.32M	93.93%34.92M	59.70%18.01M	--11.28M
Research and development costs	122.69%128.84M	69.49%57.86M	47.87%34.14M	9.09%23.09M	--21.16M
Depreciation amortization depletion	25.36%6.74M	3.96%5.38M	5.98%5.17M	15.25%4.88M	--4.24M
-Depreciation and amortization	25.36%6.74M	3.96%5.38M	5.98%5.17M	15.25%4.88M	--4.24M
Other operating expenses	-100.53%-173K	55.50%32.7M	299.30%21.03M	25.02%5.27M	--4.21M
Operating profit	141.29%39.24M	3.83%-95.02M	-98.45%-98.8M	-23.67%-49.79M	-40.26M
Net non-operating interest income expense	-90.57%-12.75M	-28.25%-6.69M	-370.94%-5.22M	52.03%-1.11M	-2.31M
Non-operating interest income	101,800.00%1.02M	--1K	----	-31.63%67K	--98K
Non-operating interest expense	104.74%13.14M	22.96%6.42M	344.09%5.22M	-51.20%1.18M	--2.41M
Total other finance cost	129.60%636K	--277K	----	----	----
Other net income (expense)	-1,076.64%-30.14M	-86.90%3.09M	695.98%23.55M	-74.14%2.96M	11.44M
Special income (charges)	---804K	----	----	----	----
-Less:Impairment of capital assets	--804K	----	----	----	----
Other non- operating income (expenses)	-1,050.58%-29.34M	-86.90%3.09M	695.98%23.55M	-74.14%2.96M	--11.44M
Income before tax	103.13%3.09M	-22.57%-98.62M	-67.86%-80.47M	-54.02%-47.94M	-31.12M
Income tax	-138.92%-2.12M	12,026.67%5.46M	101.48%45K	6.36%-3.05M	-3.26M
Net income	105.01%5.21M	-29.27%-104.08M	-79.36%-80.51M	-61.08%-44.89M	-27.87M
Net income continuous Operations	105.01%5.21M	-29.27%-104.08M	-79.36%-80.51M	-61.08%-44.89M	---27.87M
Minority interest income
Net income attributable to the parent company	105.01%5.21M	-29.27%-104.08M	-79.36%-80.51M	-61.08%-44.89M	-27.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	105.01%5.21M	-29.27%-104.08M	-79.36%-80.51M	-61.08%-44.89M	-27.87M
Basic earnings per share	104.81%0.0161	-17.54%-0.335	-63.32%-0.285	-46.15%-0.1745	-0.1194
Diluted earnings per share	104.81%0.0161	-17.54%-0.335	-63.32%-0.285	-46.15%-0.1745	-0.1194
Dividend per share
Currency Unit	AUD	AUD	AUD	AUD	AUD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Heat List

Overall

No Data

Investment Theme

Recent IPOs

Intraday-1.42%